Mitochondrial Dysfunction in the Pathogenesis of Preeclampsia.

Area of Science:

• Obstetrics and Gynecology
• Mitochondrial Biology
• Pathophysiology

Background:

• Preeclampsia affects 5-10% of pregnancies, causing significant maternal and perinatal mortality.
• The placenta is crucial for fetal development, and its function relies heavily on mitochondrial energy supply.
• Placental dysfunction is a known origin of preeclampsia, but its exact causes are still unclear.

Purpose of the Study:

• To review current knowledge on mitochondrial abnormalities in preeclampsia pathogenesis.
• To explore therapeutic strategies targeting mitochondria for preeclampsia treatment.

Main Methods:

• Review of existing scientific literature on preeclampsia and mitochondrial function.
• Synthesis of evidence linking mitochondrial dysfunction to placental pathology.
• Analysis of potential therapeutic targets within mitochondria.

Main Results:

• Mitochondrial abnormalities are strongly implicated in placental dysfunction.
• Mitochondrial damage may lead to circulating factors that cause maternal endothelial dysfunction and hypertension.
• Evidence suggests mitochondria are central to preeclampsia development.

Conclusions:

• Mitochondrial dysfunction is a key factor in the pathogenesis of preeclampsia.
• Therapeutic interventions focused on mitochondria show promise for treating preeclampsia.